Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buspirone in Attention Deficit Hyperactivity Disorder (ADHD)
IRCT138901292000N3Phase 3Completed
- Sponsor
- Behavioral Sciences Research Center
- Start
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of buspirone in attention deficit hyperactivity disorder (ADHD), sponsored by Behavioral Sciences Research Center. Started Feb 2007; status: completed.
02
Drugs
buspirone
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on IRCT138901292000N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138901292000N3.